lacosamide
Generic: lacosamide
Labeler: zydus pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
lacosamide
Generic Name
lacosamide
Labeler
zydus pharmaceuticals usa inc.
Dosage Form
INJECTION
Routes
Active Ingredients
lacosamide 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70710-1886
Product ID
70710-1886_c2dded9d-fd0c-4ddf-b7af-706fed0857d9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209465
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2022-11-10
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
707101886
Hyphenated Format
70710-1886
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lacosamide (source: ndc)
Generic Name
lacosamide (source: ndc)
Application Number
ANDA209465 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 10 VIAL in 1 CARTON (70710-1886-6) / 20 mL in 1 VIAL (70710-1886-1)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "c2dded9d-fd0c-4ddf-b7af-706fed0857d9", "openfda": {"nui": ["N0000008486"], "unii": ["563KS2PQY5"], "rxcui": ["809974"], "spl_set_id": ["16a9afd2-35a6-44a9-b1d9-ca195c8640d7"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 CARTON (70710-1886-6) / 20 mL in 1 VIAL (70710-1886-1)", "package_ndc": "70710-1886-6", "marketing_start_date": "20221110"}], "brand_name": "LACOSAMIDE", "product_id": "70710-1886_c2dded9d-fd0c-4ddf-b7af-706fed0857d9", "dosage_form": "INJECTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70710-1886", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LACOSAMIDE", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA209465", "marketing_category": "ANDA", "marketing_start_date": "20221110", "listing_expiration_date": "20261231"}